Logo

American Heart Association

  28
  0


Final ID: MP312

Total Carotid Artery Calcium Score on Standard-of-care Oncologic Computed Tomography Scans Predicts Radiation-induced Carotid Artery Disease and its Sequelae in Patients with Oropharyngeal Cancer

Abstract Body (Do not enter title and authors here): Introduction:Radiation therapy (RT) induced carotid artery disease (RICAD) is a significant contributor to morbidity and mortality of oropharyngeal cancer (OPC) survivors. Pre-existing carotid atherosclerosis is likely a risk factor for accelerated development of RICAD.Its evaluation prior to RT is not currently standard practice. This study aimed to utilize standard of care (SOC) oncologic pre-RT CT scans to quantify carotid calcific atherosclerosis and assess the role of carotid artery calcium score (CaACS) in predicting RICAD and its sequalae.
Methods:Patients with OPC treated with RT at a tertiary center during 2016-19 were identified. SOC oncologic pre-RT CT of the neck with contrast was used to estimate CaACS utilizing the CT Cardiac package of SyngoVia (Siemens Healthcare). To separate calcified plaque from contrast, density threshold of 230 HU was used.Bilateral common and internal carotid arteries were evaluated to the C1 vertebra. Patients were split into three groups based on CaACS distribution:low (values ≤ median) as reference group,medium(values between median and 75th percentile),and high (values >75th percentile).
Results:A total of 271 patients were included (mean age 61 ± 9.8, 88% male).Smoking was reported in 57%, hypertension (HTN) in 53%, dyslipidemia (DLD) in 43%, and diabetes mellitus (DM) in 14%,while 34% were on a statin prior to RT. Total median CaACS was 10.8 AU (IQR 0-140.6) with 46% having a score of 0. During a median follow up of 6.4 years (IQR 6.3-6.6), 41% developed new or worsened carotid atherosclerosis, 3.7% carotid artery stenosis >50%, 2.6% TIA or stroke, and 17% died without new or worsened carotid atherosclerosis. In a multivariate cause-specific Cox regression analysis, high CaACS was significantly associated with increased risk of the composite outcome of worsened carotid atherosclerosis, >50% stenosis, TIA or stroke (HR 2.18,95% CI[1.34-3.54]) compared to low CaACS. Hypertension was also associated with the composite outcome (2.26[1.49-3.41]) while no significant associations were noted with age, smoking, DLD, DM, or statin use. Fine-Gray analysis showed similar results.
Conclusion:In our cohort of patients with OPC, high CaACS and history of HTN prior to RT, were significantly associated with development of RICAD. Quantification of carotid artery calcific atherosclerosis utilizing SOC oncologic CT imaging may assist with patient risk stratification, guide surveillance and potentially mitigate RICAD in OPC survivors.
  • Kapadia, Taher  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Lin, Ruitao  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Abe, Junichi  ( University of Texas MD Anderson Can , Houston , Texas , United States )
  • Palaskas, Nicolas  ( UT MD Anderson Cancer Center , Houston , Texas , United States )
  • Gladish, Gregory  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Moreno, Amy  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Naser, Mohamed  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Hutcheson, Katherine  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Rosenthal, David  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Mouhayar, Elie  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Deswal, Anita  ( UT MD Anderson Cancer Center , Houston , Texas , United States )
  • Bandrey, Dhawal Sanjay  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Fuller, Clifton  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Viguet, Claire  ( Mcgovern Medical School , Houston , Texas , United States )
  • Koutroumpakis, Efstratios  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Patel, Bhumiben  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Van Bergen Diaz, Patrik Joan  ( University of Barcelona , Barcelona , Spain )
  • Shen, Jennifer  ( MD Anderson Cancer Center , Pearland , Texas , United States )
  • Mbagwu, Gabrielle  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Patin, Stephen  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Hughes, Andres  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Song, Juhee  ( MD Anderson Cancer Center , Houston , Texas , United States )
  • Author Disclosures:
    Taher Kapadia: DO NOT have relevant financial relationships | Ruitao Lin: DO have relevant financial relationships ; Consultant:Eli Lilly:Active (exists now) ; Consultant:Merck:Past (completed) | Junichi Abe: DO NOT have relevant financial relationships | Nicolas Palaskas: DO have relevant financial relationships ; Consultant:Kiniksa Pharmaceuticals:Active (exists now) | Gregory Gladish: DO NOT have relevant financial relationships | Amy Moreno: DO NOT have relevant financial relationships | Mohamed Naser: DO NOT have relevant financial relationships | Katherine Hutcheson: No Answer | David Rosenthal: No Answer | Elie Mouhayar: DO have relevant financial relationships ; Consultant:RYVU:Active (exists now) ; Consultant:SYNDAX:Active (exists now) | Anita Deswal: DO have relevant financial relationships ; Consultant:Bayer:Active (exists now) | Dhawal Sanjay Bandrey: DO NOT have relevant financial relationships | Clifton Fuller: No Answer | Claire Viguet: DO NOT have relevant financial relationships | Efstratios Koutroumpakis: No Answer | Bhumiben Patel: No Answer | Patrik Joan Van Bergen Diaz: No Answer | Jennifer Shen: DO NOT have relevant financial relationships | Gabrielle Mbagwu: DO NOT have relevant financial relationships | Stephen Patin: No Answer | Andres Hughes: DO NOT have relevant financial relationships | Juhee Song: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiac Imaging in Cancer Therapy: Risk Prediction, Detection, and AI-Driven Insight

Saturday, 11/08/2025 , 12:15PM - 01:25PM

Moderated Digital Poster Session

More abstracts on this topic:
More abstracts from these authors:
Neck Adiposity Measured on Pre-therapy Oncologic Computed Tomography Scans Predicts the Development of Radiation Therapy-induced Carotid Artery Disease in Patients with Head and Neck Cancer

Bandrey Dhawal Sanjay, Abe Junichi, Lin Ruitao, Moreno Amy, Naser Mohamed, Hutcheson Kate, Rosenthal David, Khalaf Shaden, Iliescu Cezar, Mouhayar Elie, Deswal Anita, Patel Bhumiben, Fuller Clifton, Koutroumpakis Efstratios, Van Bergen Diaz Patrik Joan, Mbagwu Gabrielle, Shen Jennifer, Kapadia Taher, Patin Stephen, Hughes Andres, Song Juhee

Longitudinal Echocardiographic Assessment of Subacute Cardiotoxicity in a Prospective Cohort of Adolescents and Young Adults with Sarcoma Treated with High-Dose Doxorubicin

Viguet Claire, Chandra Joya, Daw Najat, Hildebrandt Michelle, Livingston John, Ali Hj, Roth Michael, Kleinerman Eugenie, Deswal Anita, Koutroumpakis Efstratios, Hughes Andres, Banchs Jose, Kapadia Taher, Gilchrist Susan, Rauschendorfer Savannah, Jeyabal Prince, Song Juhee, Honey Theresa

You have to be authorized to contact abstract author. Please, Login
Not Available